4//SEC Filing
Metcalfe David A 4
Accession 0001209191-22-055356
CIK 0000708818other
Filed
Nov 1, 8:00 PM ET
Accepted
Nov 2, 5:08 PM ET
Size
13.2 KB
Accession
0001209191-22-055356
Insider Transaction Report
Form 4
Metcalfe David A
Chief Technology Officer
Transactions
- Exercise/Conversion
Common Stock
2022-11-01$14.07/sh+14,744$207,448→ 211,356 total - Exercise/Conversion
Common Stock
2022-11-01$14.20/sh+17,628$250,318→ 196,612 total - Exercise/Conversion
Stock Option (right to buy)
2022-11-01−14,744→ 107,580 totalExercise: $14.07Exp: 2025-10-31→ Common Stock (14,744 underlying) - Sale
Common Stock
2022-11-01$20.00/sh−32,372$647,485→ 178,984 total - Exercise/Conversion
Stock Option (right to buy)
2022-11-01−17,628→ 100,000 totalExercise: $14.20Exp: 2024-02-01→ Common Stock (17,628 underlying)
Footnotes (4)
- [F1]Pursuant to a 10b5-1(c) plan adopted by the reporting person on March 15, 2022.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.08. Full information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or its stockholders upon request.
- [F3]Original grant of 200,000 options granted on 2/1/2016 vested in four equal, annual installments beginning 2/1/2017.
- [F4]Original grant of 140,000 options granted on 10/31/2017 vested in four equal, annual installments beginning 10/31/2018.
Documents
Issuer
NEXTGEN HEALTHCARE, INC.
CIK 0000708818
Entity typeother
Related Parties
1- filerCIK 0001664295
Filing Metadata
- Form type
- 4
- Filed
- Nov 1, 8:00 PM ET
- Accepted
- Nov 2, 5:08 PM ET
- Size
- 13.2 KB